The herpes simplex viruses (HSV-1 and HSV-2) encode a ribonucleotide reductase consisting of two non-identical subunits (RR1 and RR2) which associate to form the active holoenzyme. To facilitate the purification and subsequent biochemical characterization of this enzyme, we have cloned the small subunit 2 of the HSV-2 ribonucleotide reductase (RRnSV-0 in a helper-independent adenovirus type 5 vector under the control of the adenovirus type 2 major late promoter. After infection of 293 cells with the recombinant virus, the amount of RR Hsv-z protein produced was eightfold higher than in HSV-2-infected cells. The specific activities of the RR Hsv-2 recombinant subunit and the RR psv-2 protein in HSV-2-infected cells were determined by their mixing with saturating amounts of isolated RR~ sv-1 subunit. By comparison of the relative amount of each RRp sv-2 subunit with its specific activity, we calculated that the recombinant protein intrinsic activity was similar to that of the protein produced in HSV-2-infected cells. These results demonstrated that the adenovirus expression vector is a good system to produce an active RR Hsv-2 subunit in fairly high amounts.
Introduction
Ribonucleotide reductase is an essential enzyme for the synthesis of deoxyribonucleotides in prokaryotic and eukaryotic cells. In nearly all systems, two different subunits (RR 1 and RR2) associate to form the active enzyme (Thelander & Reichard, 1979) . Herpes simplex viruses types 1 and 2 (HSV-1 and HSV-2) encode their own RR Hsv (136K) and RR Hsv (38K) subunits which associate tightly to form the active holoenzyme (Cohen et al., 1985; Dutia, 1983; Huszar et al., 1983) . Attempts to purify HSV ribonucleotide reductases to homogeneity have so far been largely unsuccessful. However partially purified preparations have been used to demonstrate that the enzyme has altered properties compared to the bacterial and mammalian isoenzymes. The tight association of the two subunits is independent of Mg 2÷, and its enzymic activity which does not require ATP is insensitive to dTTP and dATP inhibition (Langelier & Buttin, 1981 ; Huszar & Bacchetti, 1981 ; Averett et al., 1983 Averett et al., , 1984 Cohen et al., 1985) . Recent in vivo experiments with a mouse model have suggested that, as this enzyme is essential to the virus pathogenicity, it could be a good target for specific inhibitors of HSV replication (Cameron et al., 1988; Jacobson et al., 1989) .
Our laboratory, and others (Cohen et al., 1986a; Dutia et al., 1986) , have demonstrated that HSV ribonucleotide reductases are specifically inhibited by a nonapeptide which corresponds to the carboxy-terminal sequence of the RR~ sv subunit. The finding that the specific binding of the nonapeptide to the RR Hsv subunit prevents association of the two subunits, demonstrates that the carboxy-terminal sequence of RR Hsv is involved in the interaction with RR1Hsv (McClements et al., 1988; Paradis et al., 1988) . These observations have led to the attractive suggestion that the association of the two viral subunits could be a specific target for antiviral chemotherapy. A knowledge of the tertiary structure of the HSV ribonucleotide reductase holoenzyme would be very useful for the development of inhibitory peptides with greater potency. However these structural studies have been hampered due to the lack of large amounts of purified proteins. Attempts to express enzymically active HSV RR1 or RR2 subunits separately in, respectively, cultured human cells using a recombinant adenovirus vector or in Escherichia coli have been reported (Huang et al., 1988; Ingemarson et al., 1989) , but the yield and activity of these recombinant proteins were not greater than in HSV-infected cells. Here we report a recombinant adenovirus expression vector that produced eightfold more RR Hsv-z protein than HSV-2-infected cells.
Moreover by means of an efficient method for obtaining N. Lamarche and others RR psv preparations devoid of RR nsv, we could determine that the recombinant protein has an intrinsic activity identical to that of the protein synthesized in HSV-2-infected cells.
Methods
Cells and viruses. 293 cells and BHK-21/C13 cells were grown at 37 °C in, respectively, Dulbecco's modified Eagle's medium (DMEM) or a-modified Eagle's medium supplemented with 10% foetal bovine serum, glutamine and antibiotics. Ad5/AE~AE 3 is an adenovirus type 5 strain from which the E1 and E3 transcription units had been deleted (Gluzman et al., 1982) . These adenoviruses and Ad5-derived recombinant viruses were propagated by infecting 293 cells, a human embryo kidney cell line expressing Ad5 E 1A and E 1B functions (Graham et al., 1977) . Virions were released from the infected cells by three cycles of freezing and thawing. HSV-I (strain F) and HSV-2 (strain HG52) stocks were produced in BHK-21/C13 cells using a low m.o.i, as described previously (Langelier et al., 1978) .
Construction of plasmids and recombinant viruses. Plasmid pAdBM 1 was derived from pPyMT-2 (Davidson & Hassell, 1987; Logan & Shenk, 1984) by sequentially subcloning a 590 bp Sau3AI fragment containing the Ad5 hexon polyadenylation signal at the BlglI site located at the 3' end of the polyomavirus (PyV) middle T antigen coding sequences, and then a 750 bp XhoI-XbaI fragment from pD1 (Berkner et al., 1987) in replacement of the XhoI-XbaI fragment containing most of the PyV middle T antigen. Thus pAdBM1 contains DNA segments which, going counter-clockwise, include ( Fig. 1) : the EcoRI-SalI large fragment of the E. coli replicon pML2 (Lusky & Botchan, 1981) ; Ad5 sequences from 15.5 to 9-4 map units (m.u.); the Ad2 major late promoter; a cDNA copy of the entire Ad2 tripartite leader sequence including the 5' splicing donor site of the third leader and a 3' acceptor site from an immunoglobulin gene; a unique BamHI cloning site; the simian virus 40 (SV40) late polyadenylation signal from the BamHI site (nucleotide 2533) to the BclI site (nucleotide 2770); pBR322 sequences (nucleotides 375 to 650); the PyV early polyadenylation signal from the XbaI site (nucleotide 2522) to the HindlI site (nucleotide 2962); the Ad5 hexon polyadenylation signal from 64.0 to 62.3 m.u. and the 5' 356 bp or 1.0 to 0 m.u. of the Ad5 genome.
The cloning of the RR nsv gene into pAdBM~ proceeded as follows nsv (Fig. 1) . The sequence encoding RRz was isolated as a 2.2 kb Xhol fragment from the HSV-2 genome and cloned into the unique Xhol site of the plasmid pSV103 (Paterson et al., 1985) to generate the plasmid designated pSVRR2 nsv. We then cloned a synthetic double-stranded 16-mer oligonucleotide (5'-GATCAGATCTGCCATG-3') with compatible BamHI overhangs, into the unique BamHI restriction site of pSVRR2 nsv. The BamHI site overlaps the translation initiation site of the RR2 nsv coding sequence. Insertion of the synthetic DNA restored the ATG in-frame and created a unique BgllI site in ajacent upstream sequences. The fragment containing the RR Hsv coding sequence and including the SV40 polyadenylation signal found in pSV 103, was then released from pSVRRHSV-16 by BgllI-BclI double digestion and then inserted into the unique BamHI site of pAdBM1.
As shown in Fig. 2 , the resulting plasmid pAdBM1-RR~ sv, was used to generate recombinant virus by in vivo homologous recombination between the overlapping sequences on the linearized plasmid pAdBM ~-RR2 nsv and the large 3' fragment of the AdS genome (Berkner & Sharp, 1983 (Graham & Van Der Eb, 1973) . After the appearance of c.p.e., the culture was harvested and the viral lysates were subjected to plaque purification. Viral plaques were picked and amplified by infecting 293 cells in 24-well plates (at a cell density of l0 s cells per well). Recombinants were identified by restriction endonuclease analysis of viral DNA extracted from infected cells by the Hirt procedure (Hirt, 1967) . After positive identification, the Ad5-RR2 nsv recombinant virus was further plaque-purified and virus stocks were prepared by infecting confluent 293 cells.
Protein analysis. Confluent 293 cells (2 × 106) in 60 mm diameter dishes were infected with HSV-2, Ad5/AEIAE 3 or Ad5-derived recombinant virus at a multiplicity of 20 p.f.u./cell. At different times post-infection (p.i.), cells were harvested and lysed on ice in 100 mMNaC1, 100 mM-Tris HCI pH 8-0, 0.5% NP40 and the protease inhibitors 1 mM-PMSF, 10 p-g/ml leupeptin, 0-3 trypsin inhibitor units/ml aprotinin. Proteins were separated by SD~PAGE (Laemmli, 1970) and then stained with Coomassie blue or, for immunoblotting, were electrophoretically transferred to nitrocellulose paper in 25 m~-Tris-HCl pH 8.3 and 192 mM-glycine (Towbin et al., 1979) . The nitrocellulose was then incubated with P9 serum [diluted 1:500 with 5 ~ milk in phosphate-buffered saline (PBS)], a polyclonal rabbit serum raised against a synthetic nonapeptide corresponding to the carboxy terminus of the RR~ sv subunit (Cohen et al., 1986b) , washed in PBS including 0.1 ~ Triton X-100 and further incubated with 0.1 p-Ci/ml of ~zsI-labelled protein A (Amersham).
To measure the rate of synthesis of the RR2 Hsv-2 protein, confluent 293 cells were infected with Ad5-RR2 nsv, Ad5/AE1AE3 or HSV-2. At selected times after infection, cells were labelled with 30 p-Ci/ml of [35S]methionine (Amersham) in methionine-free medium for 2 h. The labelling of some dishes of infected cells was chased for 6 h by the replacement of the labelling medium for fresh normal medium. Protein extracts were prepared as described above, separated by SDS-PAGE and analysed after autoradiography.
Assays for ribonucleotide reductase activity. HSV-I or HSV-2 ribonucleotide reductases were partially purified from quiescent BHK-21/C 13 cells infected, respectively, with strains F or HG52 whereas the RR2 usv recombinant protein was obtained from confluent 293 ceils infected with Ad5 RR~ sv recombinant virus, as described previously (Cohen et al., 1985; Huszar & Bacchetti, 1981) . Protein concentration was measured by the Coomassie blue staining method of Bradford (1976) using serum albumin as a standard.
Ribonucleotide reductase activity was assayed by monitoring the reduction of [3H]CDP for 30 min in a final volume of 60 p.l, as detailed previously (Cohen et al., 1985) . The standard reaction mixture contained 50 mM-HEPES pH 7-8, 4 mr, i-sodium fluoride, 20 mM-DTT, 50 ~tM-CDP, 0.25 ~tCi of [3H]CDP (and 1 mM-bacitracin when inhibitory peptide was added to the assay). One unit of ribonucleotide reductase is defined as the amount of enzyme generating 1 nmol of dCDP/h under the standard assay conditions. HSV 1 RR~ sv-1 subunit isolation. Preparations of the RR1 -subunit devoid of the RR2 nsv-1 subunit were obtained by specific immunoprecipitation of the latter with P9-purified IgG (Cohen et al., 1986 b) . Typically, 1 mg of partially purified extract of HSV-1 ribonucleotide reductase was reacted for 1 h at 4 °C with an excess of purified IgG. The immune complexes and the excess of IgG were precipitated subsequently with 5 mg of Protein A-sepharose (Pharmacia) after agitation for 1 h at 4 °C. The supernatant was reincuhated with 5 mg of Protein A-sepharose to remove residual immune complexes and IgG. The resulting supernatant was lyophilized overnight and the proteins were dissolved in a minimal volume of 50 mM-HEPES pH 7.8 and 2 mM-DTT.
Slot blot densitometric quantification of RR~ sv-2 protein.
Partially purified HSV-2 ribonucleotide reductase and RR~ sv-2 recombinant protein extracts were serially diluted in 20 mM-Tris-HC1 pH 7.5 and 500 mM-NaCI. The diluted amounts of protein were fixed on nitrocellulose paper using a slot blot apparatus. The nitrocellulose was then incubated with P9 serum (1:500), washed and reacted with 125I-labelled protein A as described above. The relative amount of RR~ sv-2 protein was determined by densitometry with a LKB Ultrascan XL instrument.
Results

Construction of the Ad5-RR~ sv-2 recombinant virus
To produce the RR Hsv-2 subunit at high levels in mammalian cells, we have constructed a helper-free recombinant adenovirus, Ad5-RR Hsv, expressing the RR Hsv coding sequence under the control of the Ad2 major late promoter in the opposite transcriptional orientation from the overall direction of late gene transcription. The construction of the Ad5-RR Hsv hybrid virus proceeded in two major steps. The first step involved the subcloning of the RR2 nsv gene into the adenovirus shuttle plasmid pAdBM1 (Fig. 1) . To achieve optimal expression, the junction between the coding region of the RR Hsv-2 subunit and the expression vector was engineered such that the ATG was positioned next to the splice donor and acceptor site of the vector. The resulting plasmid, pAdBM ~-RR2 nsv, contained a hybrid transcription unit which consists of the Ad2 major late promoter, a cDNA copy of the entire Ad2 tripartite leader, a splice donor and acceptor site, and the complete genomic segment encoding the RR Hsv-2 protein followed by several polyadenylation signals. Multiple polyadenylation signals were included at the 3' end of the transcription unit to ensure efficient polyadenylation of the majority of the mRNAs, since transcription from the strong Ad2 major late promoter often leads to readthrough transcripts as seen in a number of other recombinant adenoviruses (Alkhatib & Briedis, 1988; Alkhatib et al., 1988; Berkner & Sharp, 1984; Davidson & Hassell, 1987) .
The second step consisted of the rescue of the hybrid transcription unit into infectious Ad5 by cotransfecting, in 293 cells, the plasmid pAdBM1-RR2 nsv linearized at the unique ClaI site, with ClaI-cut Ad5/AE1AE 3 viral DNA (Gluzman et al., 1982) (Fig. 2) . DNA extracted from 13 out of 24 plaque isolates had the structure corresponding to the genome of Ad5-RR~ sv depicted at the bottom of Fig. 2 , whereas the remaining viruses had the structure of Ad5/AEaAE3 as determined by restriction endonuclease analysis followed by Southern blot hybridization with the appropriate DNA probes (data not shown). The genome of Ad5-RR Hsv, which was approximately 1 ~ smaller than wild-type Ad5, remained stable upon further rounds of plaque purification and amplification to produce large stocks of virus. Similarly to its parent, Ad5/AEaAE3, the recombinant virus grew routinely to high titres in 293 cells (> 109 p.f.u./ml).
Expression of the RR~ sv-2 protein in recombinant adenovirus-RR~SV-infected cells
To study the synthesis of RR2 Hsv-2 protein, protein extracts were prepared from 293 cells infected with Clal(PvuII) ClaI ( In vivo recombination of the adenovirus RRz nsv recombinant, pAdBM~ RR~ sv linearized with ClaI was cotransfected with ClaI-cut Ad5/AE1AE 3 viral DNA in 293 cells. By in vivo recombination between homologous 9.4 to 15.5 mu. segments of plasmid pAdBM1-RR nsv and Ad5/AE~AE 3 right-arm DNA, the recombinant Ad5-RR~ sv was generated. Fig. 3(a) , where the resolved proteins were stained with Coomassie blue, the r e c o m b i n a n t adenovirus synthesized a new polypeptide in large amounts (lanes 3 to 7) that was detected in neither the A d 5 / A E l A E 3 -i n f e c t e d (lane 2) nor in the mock-infected cells (lane 1). This protein of 38K has the same electrophoretic mobility as the RR2 nsv2 protein produced in HSV-2-infected cells (lanes 8 and 9). The amount of r e c o m b i n a n t protein increased until 30 h p.i. and reached a plateau thereafter, as expected for a protein expressed under the control of the Ad2 major late promoter. By densitometric scanning of the stained bands, this m a x i m a l a m o u n t was established to be 4~ of the total intracellular proteins and contrasted with the low level of the RRz nsv-2 protein synthesized in HSV-2-infected cells which was barely detectable by Coomassie blue staining.
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To confirm the identity of the RR~ sv-2 r e c o m b i n a n t polypeptide, protein extracts were i m m u n o b l o t t e d with P9 serum. As shown in Fig. 3 (b) , this serum reacted with an identical polypeptide in either HSV-2-or A d 5 -RR2nSV-infected cells (lanes 8 and 9, and 3 to 7, respectively). As expected, none of the proteins reacted with the P9 serum in the mock-infected (lane 1) or the Ad5/AEaAE3-infected cells (lane 2). These results clearly d e m o n s t r a t e d that the R R nsv-2 r e c o m b i n a n t protein produced at high levels in Ad5-RREHSV-infected 293 cells is similar to the ribonucleotide reductase R R~ sv-2 subunit synthesized in the HSV-2-infected cells. 
Time course of RR~ sv-2 polypeptide synthesis in Ad5-RRi]SV-infected 293 cells
The rate of synthesis of the RR2 nsv-z protein was analysed by a 2 h labelling of the infected cells with [35S]methionine at different times after infection, followed by SDS-PAGE. De novo synthesis of the RR~ sv-2 recombinant protein was first observed at 12 h p.i. and rapidly increased up to 16 h. Thereafter, the rate of synthesis was maintained until 30 h (Fig. 4 , lanes 4 to 7 and data not shown). In 293 cells infected with HSV-2, the synthesis of RRz Hsv-2 protein was maximal at 8 h p.i. and decreased until 20 h where its synthesis ceased (lanes 8 and 9) as previously reported (Huszar & Bacchetti, 1981) . The maximum rate of synthesis of the RR~ sv-2 recombinant protein was threefold higher than the rate observed in HSV-2-infected cells and was maintained over a longer period of time.
The in vivo stability of the recombinant protein was studied, at 16 h and 20 h p.i. by labelling the infected cells for 2 h followed by a chase in non-radioactive medium for 6 h. The results presented in Fig. 4 (lanes 11 and 12) indicated that the labelling of the recombinant polypeptide remained as stable as the protein synthesized in HSV-2-infected cells during the 6 h chase period for both time points. This showed that the recombinant protein was fairly stable. Therefore, we concluded that the sustained and high rate of synthesis of the stable RR2 nsv-2 recombinant subunit is responsible for its higher accumulation in Ad5-RR2USV-infected 293 cells than in the parallel infection by HSV-2.
Measurement of the RR~ sv-2 recombinant protein activity
As extracts of 293 cells infected with Ad5-RRz nsv2 contain only the small subunit of HSV-2 ribonucleotide reductase, they were completely inactive when the ribonucleotide reductase assays were performed in the absence of ATP a n d Mg 2+ even with high amounts 0f ~ extract (200 ~tg protein/tube). Hence, to measure the activity of the RRz Hsv-2 subunit, a method was devised to obtain preparations of active RR~ sv free of RR2 ~sv. As P9 serum immunoprecipitates the RR~ sv protein without co-immunoprecipitation of the RR~ nsv protein (Cohen et al., 1986b) , its use easily provided supernatants depleted of RR2 nsv as demonstrated by immunoblotting (data not shown) and loss of reductase activity (Fig. 5 ). The addition of increasing amounts of RR2 Hsv-2 recombinant extracts to a small amount of such supernatants produced a rapid increase in reductase activity followed by a plateau which corresponds to the RR~ sv-1 specific activity (approx. 40 units/rag) (data not shown). This result indicates also that the recombinant small subunit was highly active. When comparable amounts of extracts of Ad5/AE~AE~-infected cells (control) were added no enzymic activity was observed. Fig. 5 illustrates an experiment done to measure the recombinant RR2 nsv-2 specific activity using two amounts of recombinant extract (2 and 5 gg). The plateau value at 2 gg gave a specific activity of 330 units/mg, whereas at 5 gg it was more difficult to attain saturating amounts of the large subunit. One additional control performed in this experiment demonstrated that the measured reductase activity was virus-specified. Indeed, addition of 100 gM-acetyl RR2HSV-(329 to 336) synthetic peptide to the mixture of the two subunits giving the highest specific activity completely abolished it. This peptide which by its specific binding to RR~ sv impairs the formation of active HSV holoenzyme has no effect on t RR~ sv2 specific activities are plateau values obtained with saturating amounts of isolated RR~ svq subunit prepared from HSV-l-infected BHK-21/C13 cells as described in Methods. Values in parentheses are expressed in relation to reductase specific activity of the RR psv-2 protein from HSV-2-infected cell extract.
:~ Relative activity is calculated as the ratio of relative specific activity to the relative amount of the RR~ sv-2 protein.
§ A similar value was obtained with saturating amounts of the isolated RR nsv-2 subunit prepared from HSV-2-infected BHK-21/C13 cells. (Gaudreau et al., 1987; Paradis et al., 1988) .
Three separate infections of 293 cells with the recombinant virus gave a mean RR Hsv-2 specific activity of 300 units/mg which represents an 8-2-fold higher value than for the subunit produced in HSV-2-infected BHK-21/C13 cells ( Table 1) . As evaluation by slot immunoblotting of the amount of protein revealed an 8.5-fold overexpression of recombinant protein, we can conclude that the intrinsic activity of RR2 nsv is equivalent in the two types of extracts. Therefore, these results demonstrated that with this adenovirus vector, RR Hsv-2 can be produced in large amounts without any detrimental effect on its activity.
Discussion
Here we report the construction and characterization of a helper-free recombinant adenovirus that expresses the RR~ sv-2 subunit. The RR2 rtsv-2 recombinant protein accumulated at a level of approximately 4~ of the total intracellular proteins. This high accumulation, which corresponds to an 8.5-fold overproduction compared to HSV-infected cells, results from a high rate of synthesis sustained over a period of at least 18 h in Ad5-RR HsvEinfected cells compared with approximately 6 h in HSV-2-infected cells. Owing to a rapid and efficient procedure to obtain an RR Hsv preparation free of RR Hsv from HSV-infected cells, we could evaluate that the intrinsic activity of the recombinant protein is as high as for the protein produced in HSV-2-infected cells. Other strategies that we and others used previously to obtain preparations of large subunit free of small subunit have yielded preparations with very low specific activities (Cohen et al., 1985; Bacchetti et al., 1986 ; see also below).
The yield of recombinant protein obtained with our adenovirus vector is comparable to the best yields reported in the past few years with similar vectors expressing proteins such as PyV middle T antigen, dihydrofolate reductase (Berkner et al., 1987) or influenza virus nucleocapsid protein (Alonso-Caplen et al., 1988) . However this expression system has not always been so efficient (reviewed in Berkner, 1988) . For example, using a similar construction designated AdRed-1, Huang et al. (1988) reported a level of production of the RR~ nsv-2 subunit in 293 cells which can be estimated roughly as 0.1 ~ of total cellular proteins (i.e. approximately 40-fold lower than the level we obtained with Ad5-RR2nSV). These authors presented results suggesting that this low yield could be attributed to an increased proteolytic degradation of the RR~ nsv-2 recombinant subunit compared to HSV-2-infected cells. Apart from the fact that the RR~ sv-2 subunit seems to be more stable than the RR~ nsv-2 subunit in their respective recombinant adenovirus-infected cells, the rate of synthesis of the RR2 nsv-2 subunit is clearly higher than that of the RR~ sv-2 subunit. Therefore the higher level of accumulation of the RR2 nsv-2 subunit relative to the RR~ nsv-2 subunit might be due, at least in part, to better genetic expression of the Ad5-RR~ sv recombinant virus possibly due to differences in the construction of the two vectors. The vector carrying RR1 nsv-2 lacks polyadenylation signals downstream of the RR~ nsv-2 coding sequences and Kozak's consensus sequence, GCC (Kozak, 1986) , in position -3 of the initiation translation site; these are both present in our RR2 nsv-2 vector. The absence of these two elements could have reduced the translation efficiency or the stability of the RR~ sv2 mRNA.
This adenovirus expression vector represents a major improvement on 293 or RAT-2 cell lines constitutively expressing the RR2 nsv-2 subunit under the control of ~its own promoter (Huang et at., 1988; A. S6guin & Y. Langelier, unpublished data) . Indeed the level of RR2 nsv-2 protein produced in the best 293 and RAT-2 stable cell lines was respectively 16-and 40-fold lower than in Ad5-RRznSV-2-infected 293 cells and its activity was barely detectable. Furthermore the RRz nsv-I subunit was recently purified by immunoaffinity from an E. coli recombinant expressing the protein under the control of the tac promoter at a level of 30 ~g/t of culture (Ingemarson et al., 1989) . This low yield (approx. 0-1 ~ of total bacterial protein) will require 100 1 of bacterial culture to obtain 1 mg of pure protein, the lower limit to start crystallographic studies. With the adenovirus system described here, 2.5 x l0 s infected 293 cells are sufficient to obtain the same amount of protein. In addition, as the protein is more abundant in the starting material (4~ compared to 0.19/o), it will be easier to purify in large amounts by classical chromatographic methods. Moreover, this eukaryotic system will allow the study of the importance of post-translational modifications such as phosphorylation on the biological activity of RR2 nsv and also its interaction(s) with other cellular or viral proteins. Therefore, it is more advantageous in many respects than the prokaryotic system. High level expression of the RRz nsv-2 subunit, obtained in this present study, will greatly facilitate its purification to homogeneity. These preparations of the RR2 nsv-2 recombinant subunit have been useful already for measurement of the specific activity of the RR~ sv subunit in different extracts of infected cells or in the course of its purification. Furthermore, when both purified HSV-2 ribonucleotide reductase subunits are available, this system will be an invaluable tool for the design of better inhibitors of this essential viral enzyme.
